Electrochemical Detection of Alzheimer’s Disease Biomarker, β-Secretase Enzyme (BACE1), With One-Step Synthesized Reduced Graphene Oxide

β-Secretase1 (BACE1) catalyzes the rate-limiting step in the generation of amyloid-β peptides, that is, the principal component involved in the pathology of Alzheimer’s disease (AD). Recent research studies show correlation between blood and cerebrospinal fluid (CSF) levels of BACE1 with the pathoph...

Descripción completa

Detalles Bibliográficos
Autores principales: Dey, Jhilik, Roberts, Akanksha, Mahari, Subhasis, Gandhi, Sonu, Tripathi, Prem Prakash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987718/
https://www.ncbi.nlm.nih.gov/pubmed/35402415
http://dx.doi.org/10.3389/fbioe.2022.873811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987718/
https://www.ncbi.nlm.nih.gov/pubmed/35402415
http://dx.doi.org/10.3389/fbioe.2022.873811

Ejemplares similares